Delta variant renders herd immunity from Covid ‘mythical’

Head of Oxford Vaccine Group rules out overall immunity, but also questions need for booster jabs

Reaching herd immunity is “not a possibility” with the current Delta variant, the head of the Oxford Vaccine Group has said.

Giving evidence to MPs on Tuesday, Prof Sir Andrew Pollard said the fact that vaccines did not stop the spread of Covid meant reaching the threshold for overall immunity in the population was “mythical”.

“The problem with this virus is [it is] not measles. If 95% of people were vaccinated against measles, the virus cannot transmit in the population,” he told the all-party parliamentary group (APPG) on coronavirus.

“The Delta variant will still infect people who have been vaccinated. And that does mean that anyone who’s still unvaccinated at some point will meet the virus … and we don’t have anything that will [completely] stop that transmission.”

Although the existing vaccines are very effective at preventing serious Covid illness and death, they do not stop a fully vaccinated person from being infected by the virus that causes Covid-19.

The concept of herd or population immunity relies on a large majority of a population gaining immunity – either through vaccination or previous infection – which, in turn, provides indirect protection from an infectious disease for the unvaccinated and those who have never been previously infected.

Data from a recent React study conducted by Imperial College London suggests that fully vaccinated people aged 18 to 64 have about a 49% lower risk of being infected compared with unvaccinated people. The findings also indicated that fully vaccinated people were about half as likely to test positive after coming into contact with someone who had Covid (3.84%, down from 7.23%).

About 75% of all UK adults have now received both their jabs.

The health secretary, Sajid Javid, said on Tuesday that plans were in place to start offering Covid booster jabs to the most vulnerable groups in the UK from next month. He said that the flu jab would be offered at the same time.

But Pollard – who chairs Joint Committee on Vaccination and Immunisation (JCVI) but is not specifically a member of the Covid JCVI committee – questioned whether boosters would be needed.

“The time we would need to boost is if we see evidence that there was an increase in hospitalisation – or the next stage after that, which would be people dying – amongst those who are vaccinated. And that is not something we are seeing at the moment,” he said.

Even if vaccine-induced antibody levels waned, our immune systems would probably remember the vaccination for decades and offer a degree of protection if exposed to the virus, he said. “So, there isn’t any reason at this moment to panic. We’re not seeing a problem with breakthrough severe disease.”

The question of whether or not to vaccinate under-16s, as countries including the US, Ireland and Israel have done, has also provoked scientific debate in the UK.

The JCVI has recommended only vulnerable children aged 12 to 15 be vaccinated, and those who live with at-risk adults. Some critics have said that rich countries with high adult vaccine coverage, such as the UK, should not be hoarding doses for children but should donate those doses to poor countries, many of which have barely vaccinated any of their most at-risk populations.

But Prof Devi Sridhar, the chair of global public health at the University of Edinburgh, pointed out that the only vaccine authorised for use in children aged 12 to 15 in the UK was the Pfizer/BioNTech vaccine.

“I think actually the real issue is not about vaccinating kids versus the world – it’s what do we do about boosters that is being discussed in rich countries, because those are the doses that could be going abroad,” she said.

“Luckily … we have a very effective vaccine in AstraZeneca that can be used for the world, but it’s not going to solve our children issue here.”

• This article was amended on 11 August 2021. Figures showed fully vaccinated people were about half as likely to test positive after coming into contact with someone who had Covid, rather than “three times less likely” as an earlier version said.


Natalie Grover Science correspondent

The GuardianTramp

Related Content

Article image
Offshoot of Covid Delta variant on the rise in England
UK Health Security Agency monitoring AY.4.2 as daily cases at highest level since late July

Nicola Davis

19, Oct, 2021 @11:09 AM

Article image
The Covid Delta variant: how effective are the vaccines?
Analysis: what protection do they offer against infection, hospital admission and death?

Nicola Davis Science Correspondent

15, Jun, 2021 @2:38 PM

Article image
Delta variant causes more than 90% of new Covid cases in UK
Variant first discovered in India believed to spread more easily and be more resistant to vaccines

Nicola Davis Science correspondent

11, Jun, 2021 @12:22 PM

Article image
Brazilian Covid variant: what do we know about P1?
What threat does variant that is causing devastation in Brazil pose, and how is it different?

Sarah Boseley Health editor

08, Apr, 2021 @2:14 PM

Article image
What can England do to combat the Indian Covid variant?
A list of possible measures that could be taken by the government to limit the spread of the variant

Peter Walker

14, May, 2021 @4:54 PM

Article image
Delta variant doubles risk of hospitalisation, new study finds
Outbreak of Delta Covid cases likely to put strain on health services in areas with low vaccination rates, experts say

Natalie Grover Science correspondent

27, Aug, 2021 @10:30 PM

Article image
Covid vaccines may need updating to protect against new variant, study suggests
Neutralising ability of antibodies typically falls eight-fold with South African variant

Ian Sample and Linda Geddes

20, Jan, 2021 @4:15 PM

Article image
Delta Plus Covid variant: what is it and should we be concerned?
Same mutation of Delta Plus is found in Beta variant, which is partially resistant to vaccines

Ian Sample

23, Jun, 2021 @1:28 PM

Article image
Scientists call for Covid herd immunity strategy for young
Critics describe proposal to isolate vulnerable, disabled and older people as ‘grotesque’

Ian Sample Science editor

06, Oct, 2020 @6:16 PM

Article image
Scientists appeal for calm over new Covid variant in South Africa
Questions raised over potential effect on vaccines as health secretary says he is ‘incredibly worried’

Sarah Boseley Health editor

04, Jan, 2021 @4:26 PM